3,6,9-Trioxo-1-phenyl-2-oxa-4,7,10-triazadodecan-12-oic acid

Catalog No. :
ACSOPL748
CAS No. :
2566-20-3
Molecular Formula :
C14H17N3O6
Molecular Weight :
323.30

IUPAC Name:((benzyloxy)carbonyl)glycylglycylglycine

3,6,9-Trioxo-1-phenyl-2-oxa-4,7,10-triazadodecan-12-oic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$69.00Login to see priceIn stockIn stock
10g97%$121.00Login to see priceIn stockIn stock
25g97%$250.00Login to see priceIn stockInquiry
100g97%$799.00Login to see priceIn stockInquiry
500g97%$3068.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,6,9-Trioxo-1-phenyl-2-oxa-4,7,10-triazadodecan-12-oic acid
IUPAC Name((benzyloxy)carbonyl)glycylglycylglycine
MDL No.MFCD00037789
Molecular FormulaC14H17N3O6
Molecular Weight323.30
SMILESO=C(O)CNC(CNC(CNC(OCC1=CC=CC=C1)=O)=O)=O
InChI KeyKPAYASDFVKQWMA-UHFFFAOYSA-N
SynonymN-CARBOBENZOXY-GLYCYLGLYCYLGYLINE;N-BENZYLOXYCARBONYLGLYCYLGLYCYLGLYCINE;Z-GLY-GLY-GLY-OH;Z-GLYCYL-GLYCYL-GLYCINE;Z-GLU(OTBU)-OH;N-carbobenzyloxy-Gly-Gly-Gly;3,6,9-Trioxo-1-phenyl-2-oxa-4,7,10-triazadodecan-12-oic acid;Z-Gly-Gly-Gly-OH≥ 99% (HPLC)
CAS No.2566-20-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACSOPL748 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSOPL748 route product structure diagram
    ACSOPL7482566-20-3 In Stock
Inquiry

2. ACSOPL748 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSOPL748 route product structure diagram
    ACSOPL7482566-20-3 In Stock
Inquiry

Comments (0)